Latest
The prospects and perils of reclassifying cannabis as a less dangerous controlled substance
The DEA's decision to reclassify cannabis from Schedule I to Schedule III has significant implications. This acknowledges cannabis' medicinal value and could lead to increased access to medical cannabis. The move could also benefit the cannabis industry financially and have a positive impact on other controlled substances. However, it does...
Five reasons why Australia is leading the way in cannabinoid research
Dr Sud Agarwal, CEO of iNGENū CRO, highlights Australia's dominant position in cannabinoid research. He attributes this to regulatory efficiency, economic incentives, clinical expertise, patient recruitment, societal acceptance, and cost effectiveness. Australia’s favourable environment has attracted partnerships with both Australian and international companies, establishing the country as a premier destination...
MedReleaf and Aurora Cannabis launch new flower range in Australia
MedReleaf and Canadian owner Aurora Cannabis introduced a new range of dried cannabis flower in Australia, developed and manufactured by Aurora and distributed by MedReleaf through prescriptions. The products include proprietary cultivars grown by Aurora and the relaunch of Vespera under the Aurora brand. This expanded offering aims to meet...
ECS Botanics founder Alex Keach sells 50m shares and steps down from the board
ECS Botanics founder Alex Keach has sold half of his stake in the company, netting $750,000 after resigning as a board director. This structured sell-down, due to personal financial circumstances, prohibits further sales until the FY2024 financial results. Meanwhile, MD Nan-Maree Schoerie has significantly increased her stake in the company,...
“Legalize It” Says Bloke Carrying On At Nimbin Mardi Grass Like It Was Ever Illegal To Begin With
Brayden Hills, a young man from NSW's Northern Rivers, is still recovering from Nimbin's Mardi Grass festival. Known for his on-and-off relationship with employment, he carried a bag of weed throughout the festival. The event, a colourful gathering featuring a bong toss and a Cannabis Law Reform Protest/Rally, left Hills...
‘Protectionism doesn’t work’, Biortica chief warns as industry urged to take collaborative approach on imports
Calls are rising for stricter governance in the import of medicinal cannabis in Australia. Biortica CEO, Tom Varga, advocates for a collaborative approach to address industry challenges. He proposes the formation of an industry steering committee involving various stakeholders to address quality issues and regulate imports, with an emphasis on...
Featured Articles
Local Cannabis Scientist Takes Action After Spelling Errors at Melbourne Cannabis Education Seminar
Remember the last time you caught a spelling error in a professional presentation? It’s a minor mistake that reflects a broader challenge in our industry: a widespread need for accurate, up-to-date scientific cannabis plant knowledge. As a cannabis molecular scientist specialising in functional genetics, I'm here to illuminate one of...
Read more
Driving Laws for Medicinal Cannabis Patients: An Update on Australia’s Progress | CannabisNews.au
In the evolving landscape of medicinal cannabis in Australia, a critical conversation looms large: the driving laws for patients. While the plant's medicinal use has been legal since 2016, the road rules for those under its treatment have remained, for the most part, rigid and unforgiving. It's a topic that,...
Read more
Cannabis Crossroads: Australia’s Cannabis Industry at a Pivotal Moment – CannabisNews.au
As we navigate through an unprecedented year for the Australian cannabis industry, several key issues have emerged that demand our attention. Local cultivators are clamoring for support as they find themselves squeezed by imported products that often undercut them on price and on quality. Alarmingly, the Therapeutic Goods Administration (TGA),...
Read more
Australia’s Medicinal Cannabis Overprescription and Drug Interaction Risks Exposed
A study conducted by researchers from the NSW Department of Health, University of Sydney, Swinburne University, Drug and Alcohol Clinical Research and Improvement Network, and the Lambert Initiative for Cannabinoid Therapeutics, recently published in PLOS ONE, sheds light on the prescribing patterns of medicinal cannabis (MC) in Australia. Through an...
Read more
Will the movement to legalize psychedelics succeed?
Interest in psychedelics, such as psilocybin and LSD, is growing, with some locations easing criminal bans. Robert Mikos of Vanderbilt Law School discusses the challenges of legalising psychedelics federally. He highlights obstacles of rescheduling, congressional legislation, and constitutional challenges. He suggests...
Read more
The Heart of the Matter: Exploring CBD’s Potential in Cardiovascular Treatment
As our understanding of cannabis and its components deepens, the spotlight increasingly falls on Cannabidiol (CBD)—a non-psychoactive compound that might just be a game-changer for treating cardiovascular diseases. A recent review by Nadia Martinez Naya and her team ( Division...
Read more
Curated News for the Australian Cannabis Community
© CannabisNews.au 2024